FindTrial
Sign In

CADD-Legacy® 1400 ambulatory infusion pump

DEVICE7 trials

Sponsors

AbbVie (prior sponsor, Abbott), AbbVie

Conditions

Advanced Idiopathic Parkinson's DiseaseAdvanced Parkinson's DiseaseDyskinesiasParkinson's DiseaseSevere Motor Fluctuations

Phase 3

Levodopa-Carbidopa Intestinal Gel Open-Label Study in Advanced Parkinson's Disease
CompletedNCT00335153
AbbVie (prior sponsor, Abbott)Advanced Parkinson's Disease
Start: 2008-01-31End: 2012-06-30Updated: 2015-01-16
Study of Efficacy, Safety and Tolerability of Levodopa-Carbidopa Intestinal Gel in Levodopa-Responsive Parkinson's Subjects
CompletedNCT00357994
AbbVie (prior sponsor, Abbott)Advanced Parkinson's Disease
Start: 2009-01-31End: 2011-10-31Updated: 2015-01-16
Safety/Efficacy Study of Levodopa-Carbidopa Intestinal Gel in Parkinson's Subjects
CompletedNCT00360568
AbbVie (prior sponsor, Abbott)Dyskinesias, Parkinson's Disease, Severe Motor Fluctuations
Start: 2009-06-30End: 2012-10-31Updated: 2015-01-16
Open Label Continuation Treatment Study With Levodopa-Carbidopa Intestinal Gel in Advanced Parkinson's Disease
CompletedNCT00660673
AbbVieAdvanced Parkinson's Disease
Start: 2009-11-13End: 2021-11-30Updated: 2022-12-02
Study of Efficacy, Safety and Tolerability of Levodopa-Carbidopa Intestinal Gel in Levodopa-Responsive Parkinson's Subjects
CompletedNCT00660387
AbbVie (prior sponsor, Abbott)Advanced Parkinson's Disease
Start: 2009-12-31End: 2011-10-31Updated: 2015-01-16
A Study to Assess the Efficacy, Safety and Tolerability of ABT-SLV187 Monotherapy in Subjects With Advanced Parkinson's Disease (PD) and Persistent Motor Complications, Despite Optimized Treatment With Available Anti-Parkinsonian Medications
CompletedNCT01960842
AbbVieAdvanced Parkinson's Disease
Start: 2013-10-31End: 2015-03-31Updated: 2018-05-30

Phase 4

Long-term Study of Duodopa (Levodopa/Carbidopa) in Advanced Parkinson's: Health Outcomes & Net Economic Impact
CompletedNCT00141518
AbbVie (prior sponsor, Abbott)Advanced Idiopathic Parkinson's Disease
Start: 2006-03-31End: 2011-04-30Updated: 2016-07-18

Related Papers

The effect of functional status impairment on nursing home admission risk among patients with advanced Parkinson’s disease
Journal of Medical Economics2019-11-159 citations
Long-term safety and efficacy of levodopa-carbidopa intestinal gel in advanced Parkinson's disease.
2018-03-2362 citations
Effect of levodopa-carbidopa intestinal gel on resting tremors in patients with advanced Parkinson's disease.
2016-07-146 citations
Efficacy and Safety of Levodopa-Carbidopa Intestinal Gel from an Open-Label Study in Japanese, Taiwanese, and Korean Patients with Advanced Parkinson’s Disease (P5.362)
Neurology2016-04-051 citations
Continuous intrajejunal infusion of levodopa-carbidopa intestinal gel for patients with advanced Parkinson's disease: a randomised, controlled, double-blind, double-dummy study.
2013-12-20470 citations